Cibus (NASDAQ:CBUS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Cibus (NASDAQ:CBUS) from a sell rating to a hold rating in a research note published on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cibus in a research report on Friday, September 25th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Cibus currently has an average rating of “Hold” and a consensus price target of $9.00.

Cibus Stock Performance

CBUS opened at $1.68 on Friday. The stock’s 50 day moving average price is $1.69 and its 200-day moving average price is $1.64. Cibus has a one year low of $1.09 and a one year high of $4.19. The stock has a market cap of $128.40 million, a price-to-earnings ratio of -1.02 and a beta of 1.57.

Cibus (NASDAQ:CBUS) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.10). The business had revenue of $0.99 million for the quarter, compared to the consensus estimate of $1.70 million. Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%. As a group, analysts predict that Cibus will post -1.13 earnings per share for the current fiscal year.

Institutional Trading of Cibus

Several institutional investors and hedge funds have recently modified their holdings of CBUS. Dimensional Fund Advisors LP bought a new position in Cibus in the first quarter worth approximately $33,000. Renaissance Technologies LLC raised its position in Cibus by 42.5% during the 1st quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock valued at $196,000 after purchasing an additional 29,500 shares in the last quarter. Rockland Trust Co. bought a new stake in Cibus during the 2nd quarter valued at $41,000. OMERS ADMINISTRATION Corp purchased a new stake in shares of Cibus in the 1st quarter worth $66,000. Finally, Bank of America Corp DE lifted its holdings in shares of Cibus by 324.2% in the 1st quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock worth $147,000 after buying an additional 56,830 shares during the period. Institutional investors own 33.81% of the company’s stock.

About Cibus

Cibus, Inc is an agricultural biotechnology company focused on developing and commercializing gene-edited traits for major crops. Its technology is designed to make precise changes to a plant’s existing genes without introducing foreign DNA, supporting the development of improved crop varieties through a process intended to resemble conventional breeding.

The company’s product development programs target traits such as herbicide tolerance, disease resistance, improved yield, and other characteristics intended to benefit farmers, seed companies, and the broader food and agriculture supply chain.